Skip to content
Clinical Trials – home
Amsterdam UMC Stichting
Sponsor

Amsterdam UMC Stichting

The Netherlands De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands

About the sponsor

Amsterdam UMC conducts clinical research across a broad range of cancer types, with strong activity in pancreatic cancer, esophageal cancer, lung cancer, melanoma, breast cancer, bladder cancer, colorectal cancer, prostate cancer, and cholangiocarcinoma. Its studies also include advanced and metastatic disease, along with tumour-focused imaging and immunotherapy-related work.

  • Pancreatic cancer
  • Esophageal and esophagogastric cancer
  • Melanoma and skin cancer
  • Lung and bladder cancer
  • Tumour imaging and immunotherapy

Research interests extend to surgical oncology, perioperative treatment, and biomarker-driven approaches in gastrointestinal and solid tumours.

About Specializations

Amsterdam UMC Stichting runs clinical trials in conditions such as Non-small cell lung cancer, Multiple sclerosis, Post-acute COVID-19 syndrome, Crohn's disease, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

148 clinical trials

Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:INDAPAMIDE HEMIHYDRATE
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Fludeoxyglucose (18F)
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Flutemetamol (18F)
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Methotrexate
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years
  • Substances:Methotrexate
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
  • Substances:Voclosporin
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Estradiol
  • Sponsor:Amsterdam UMC Stichting
Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:SONLICROMANOL HYDROCHLORIDE
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Tadalafil
  • Sponsor:Amsterdam UMC Stichting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Amsterdam UMC Stichting

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.